<DOC>
	<DOC>NCT00647907</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of Vfend for the treatment of fungal infections</brief_summary>
	<brief_title>A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Cryptococcosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Systemic or invasive fungal infection Infection caused by organism for which there is no current treatment or infection with evidence of failure and/or intolerance to treatment with approved antifungal agents Liver function test abnormalities Renal disease Fungal infections not considered to be invasive or systemic</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>